Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TheBusDriver who wrote (12013)	1/26/2003 8:59:44 AM
From: Ron Nairn	Read Replies (1) of 14101

A re-read of the pricing announcement states one thing very clearly. "The Canadian launch of the company's lead product, PENNSAID". Not "if or when approved" but that "is" what proceeds "will" be used for. Dimethaid announces pricing of rights offering... TORONTO, Jan. 23 /CNW/ - Specialty pharmaceutical company, Dimethaid Research Inc. (TSX: DMX) is pleased to announce that it has priced its shareholder rights offering... Proceeds will be used for general corporate purposes, including the Canadian launch of the company's lead product, PENNSAID(R), as well as for capital expenditures and development of new products based on the company's proprietary technology platforms. ...I conclude that since Dec 2, when DMX rec'd HC's approvable letter, that negotiations re labelling have progressed to the point where DMX has in hand, an acceptable labelling proposal, subject to DMX's execution of the paperwork. There may be some minor modifications and signatures on DMX's part but I believe DMX is finally at the stage where they control the outcome and can and have stated in the rights pricing PR that PENNSAID will be launched in Canada. And the rights proceeds have been earmarked for that specific purpose. Anything short of that would in my opinion be an outright lie. Rondo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next